Pioneering pharmaceutical firm Vectura is planning to develop a major research and development centre of excellence as it looks for further global growth opportunities under new owner, tobacco group Philip Morris International (PMI). The Chippenham-headquartered group, which was controversially acquired by PMI for £1.1bn last September, says the centre, pictured, on the Bristol & Bath...